Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Neural Computing & Applications|May 8, 2023
An optimized model for network intrusion detection systems in industry 4.0 using XAI based Bi-LSTM frameworkS Sivamohan, S S Sridhar
IEEE Transactions on Nanobioscience|November 9, 2022
A Deep Learning Regression Model for Photonic Crystal Fiber Sensor With XAI Feature Selection and AnalysisMochitha Vijayan, S S Sridhar, Dhinakaran Vijayalakshmi
Current Oncology (Toronto, Ont.)|April 21, 2010
A review of the patterns of docetaxel use for hormone-resistant prostate cancer at the Princess Margaret HospitalS N Chin, L Wang, M Moore, et al.
The American Journal of Cardiology|October 1, 1978
Significance of left axis deviation in patients with chronic left bundle branch blockR C Dhingra, F Amat-Y-Leon, C Wyndham, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 9, 2020
Adverse event profile for immunotherapy agents compared with chemotherapy in solid organ tumors: a systematic review and meta-analysis of randomized clinical trialsD E Magee, A E Hird, Z Klaassen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 19, 2011
A phase 2 study of patupilone in patients with metastatic castration-resistant prostate cancer previously treated with docetaxel: Canadian Urologic Oncology Group study P07aK N Chi, E Beardsley, B J Eigl, et al.
ESMO Open|June 12, 2026
Avelumab first-line maintenance for advanced urothelial carcinoma: long-term outcomes from the JAVELIN Bladder 100 trial in patients with high body mass index or diabetes mellitusJ B Aragon-Ching, S Gupta, P Grivas, et al.
The Journal of Urology|May 25, 2021
Real-World Practice Patterns and Predictors of Continuous versus Intermittent Androgen Deprivation Therapy Use for Prostate Cancer in Older MenD C Cheung, S M H Alibhai, L J Martin, et al.
Current Oncology (Toronto, Ont.)|May 3, 2019
A network approach to developing immuno-oncology combinations in CanadaV Higenell, R Fajzel, G Batist, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Borealis-1: a randomized, first-line, placebo-controlled, phase II study evaluating apatorsen and chemotherapy for patients with advanced urothelial cancerJ Bellmunt, B J Eigl, E Senkus, et al.
Pageof 2